The risks of pulmonary embolism and upper gastrointestinal bleeding beyond 35 days after total hip replacement for coxarthrosis among middle-aged patients: A cross-over cohort

摘要

Prophylactic anticoagulation is recommended up to 35 days after total hip replacement (THR). Although several observational studies have assessed the incidence of thrombotic events or bleeding events after THR, the corresponding measures of association have never been studied concomitantly. Here, we evaluated the duration of the elevated risks (relative to the baseline risk) of both venous thromboembolic events and bleeding events after THR for coxarthrosis among middle-aged patients.